Oasis Pharma And Phytomolecules Private Limited - Company Profile

It is a pharma private limited company based in Chandigarh, Chandigarh, India, established in 2007.
2007 Chandigarh, Chandigarh, India Active
Last Updated:
Access Report
About Oasis Pharma And Phytomolecules Private Limited

Oasis Pharma And Phytomolecules Private Limited, a active private limited company, was established on 08 May 2007 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100CH2007PTC045485. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹8.00 Cr and a paid-up capital of ₹8.00 Cr.

It upholds a compliant status. Employing 11 professional, Its leadership includes Sanjay Dhir (Managing Director), Sanjeev Kumar (Director). Past directors included Rajiv Sharma, Gaurav Verma, Satish Kumar. It holds ₹10.30 Cr open charges and ₹8.97 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot 194-195. 3Rd Floor, Industrial Area, Phase-Ii, Chandigarh, Chandigarh, 160002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100CH2007PTC045485

  • Registration Number

    045485

  • Incorporation Date

    08 May 2007

  • Authorized Capital

    ₹8.00 Cr

  • Paid-Up Capital

    ₹8.00 Cr

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 8.00 Cr
  • Paid Up Capital ₹ 8.00 Cr
  • Company Age 18 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 10.30 Cr
  • Satisfied Charges ₹ 8.97 Cr
  • Revenue Growth **** 32971.90%
  • Profit Growth **** 43.02%
  • Ebitda **** 30.41%
  • Net Worth -90.07%
  • Total Assets -13.72%
Company report

Oasis Pharma And Phytomolecules Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Oasis Pharma And Phytomolecules Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Oasis Pharma And Phytomolecules Private Limited?
Current Directors
Name Designation Appointment Date Status
Sanjay Dhir Managing Director 15 Jan 2015 Current
Sanjeev Kumar Director 12 Dec 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 28 Sep 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2014 Past
Pramod Abcsdd Director 30 Jun 2020 Past
Pramod Abcsdd Additional Director 29 Sep 2016 Past
Pramod Abcsdd Director 01 Feb 2016 Past
Pramod Abcsdd Director 08 Feb 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Oasis Pharma And Phytomolecules.

Oasis Pharma And Phytomolecules Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 32971.9% increase. The company also saw a substantial improvement in profitability, with a 43.02% increase in profit. The company's net worth observed a substantial decline by a decrease of 90.07%.

Oasis Pharma And Phytomolecules revenue growth over time
Oasis Pharma And Phytomolecules profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 32971.90%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -13.72%
*******
*******
*******
*******
Profit or Loss
*******
 43.02%
*******
*******
*******
*******
Net Worth
*******
 -90.07%
*******
*******
*******
*******
EBITDA
*******
 30.41%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Oasis Pharma And Phytomolecules?

In 2021, Oasis Pharma And Phytomolecules had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹103,000,000.00

Satisfied Charges

₹89,705,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 10.00 Cr
  • Deputy Director Of Industries : 0.30 Cr
Latest Charge Details
Date Lender Amount Status
30 Jun 2022 Hdfc Bank Limited ₹10.00 Cr Open
01 Jan 2014 Deputy Director Of Industries ₹3.00 M Open
30 Nov 2016 Hdfc Bank Limited ₹4.17 Cr Satisfied
29 Nov 2009 Uco Bank ₹4.80 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Oasis Pharma And Phytomolecules?

Oasis Pharma And Phytomolecules has a workforce of 11 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Oasis Pharma And Phytomolecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oasis Pharma And Phytomolecules's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Oasis Pharma And Phytomolecules
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Oasis Pharma And Phytomolecules Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Oasis Pharma And Phytomolecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 10.00 Cr registered on 30 Jun 2022 with Charge ID 100591694 was modified on 23 Jan 2024. was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100591694 was registered on 30 Jun 2022. was completed.

  • Charges

    Progress on A charge registered on 30 Nov 2016 via Charge ID 100064233 with Hdfc Bank Limited was fully satisfied on 05 Aug 2021. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 4.17 Cr registered on 30 Nov 2016 with Charge ID 100064233 was modified on 28 Mar 2017. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Oasis Pharma And Phytomolecules Private Limited?

The CIN of Oasis Pharma And Phytomolecules Private Limited is U24100CH2007PTC045485.

Where is Oasis Pharma And Phytomolecules Private Limited headquartered?

Oasis Pharma And Phytomolecules Private Limited is headquartered at Plot 194-195. 3Rd Floor, Industrial Area, Phase-Ii, Chandigarh, Chandigarh, 160002.

When was Oasis Pharma And Phytomolecules Private Limited incorporated?

Oasis Pharma And Phytomolecules Private Limited was incorporated on 08 May 2007.

Who are the current directors of Oasis Pharma And Phytomolecules Private Limited?

The current directors of Oasis Pharma And Phytomolecules Private Limited are

What is the primary industry of Oasis Pharma And Phytomolecules Private Limited?

The primary industry of Oasis Pharma And Phytomolecules Private Limited is Manufacturing.

Is Oasis Pharma And Phytomolecules Private Limited a listed company?

Oasis Pharma And Phytomolecules Private Limited is unlisted.

What is the capital structure of Oasis Pharma And Phytomolecules Private Limited?

The authorized capital of Oasis Pharma And Phytomolecules Private Limited is ₹8.00 Cr, and the paid-up capital is ₹8.00 Cr.

What is the compliance status of Oasis Pharma And Phytomolecules Private Limited?

The compliance status of Oasis Pharma And Phytomolecules Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available